The CYNAERA Suites
Activate Terrain Intelligence in 24 Hours
CYNAERA transforms decades of fragmented research into modular intelligence systems that anyone, universities, governments, or biotech leaders, can deploy immediately.
Each suite is a complete product: scientifically validated, institution-ready, and licensed for instant activation.
Choose your starting point below. Every license includes 12-month access, live updates, and secure onboarding.
Terrain Intelligence Core – Institutional Lite License
$125,000 / 12-month license
Model how infections, toxins, and stressors converge.
The Terrain Intelligence Core links Pathophysiology of IACC, BST™ Logic, and the PCT Index to map real-time system breakdowns. Use it to explore environment-immune interactions and predict terrain instability before symptoms escalate.
-
Full read-only API with live environmental overlays
-
Includes 12-month update access and remote support
-
License covers up to 10 researchers or analysts
→ [Buy Now – Activate in 24 Hours]
Remission Roadmap Platform – Institutional Lite License
$175,000 / 12-month license
Turn unpredictable recovery into predictable modeling.
CYNAERA’s remission pathway algorithms identify stabilization patterns across Long COVID, ME/CFS, and post-viral syndromes—helping biotech and clinical teams design targeted trials and therapies.
-
Patient-level remission probability dashboard
-
12-month update stream + 2 onboarding sessions
-
Covers up to 15 licensed users
→ [Buy Now – Activate in 24 Hours]
Public Health Intelligence OS – Regional Pilot License
$225,000 / 12-month license
Terrain awareness for governments and health agencies.
Integrating US-CCUC™, RAVYNS™, and CYNAERA-ESA™, this suite provides cross-condition situational awareness and disaster-health forecasting for agencies and contractors.
-
Preloaded with FEMA and VA-compatible data layers
-
Generates regional dashboards within 24 hours
-
Includes training for up to 20 staff
→ [Buy Now – Activate in 24 Hours]
Economic Impact Forecaster – Standard License
$150,000 / 12-month license
Quantify the cost of inaction.
The Forecaster translates prevalence and disability data into GDP, workforce, and insurance metrics so policymakers and reinsurers can price risk accurately and model intervention ROI.
-
Plug-and-play dashboard + exportable fiscal models
-
12-month update access with support
-
Covers up to 10 institutional users
→ [Buy Now – Activate in 24 Hours]
Choose your pricing plan
Starter
4,999$Every monthIdeal for small labs and advocacy groups getting started with trial simulations. Run up to 5 simulations per month with instant drag‑and‑drop CSV uploads. 1 active project. Email‑only support- Best Value For Growing Teams
Professional
6,999$Every monthPerfect for growing biotech and clinical‑ops teams managing multiple protocols. Run up to 10 simulations per month. Up to 3 active projects. Weekly office‑hours for troubleshooting + email support 
Enterprise
9,999$Every monthTailored for large research consortia and in‑house CROs. Run up to 20 simulations per month 7 active projects Dedicated 1:1 advisory + email support Optional Co‑branded white paper per project
Key Features
Proprietary Smart Engine
Our modular PK/PD and endpoint library adapts to any indication so you can launch disease‑specific models in minutes.
Flexible Multi‑Module Design
Mix antivirals, mitochondrial support, microclot clearance, mast‑cell stabilization and anti‑cytokine kinetics into one unified protocol with a click.
Real‑Time Dynamic Endpoints
Track days‑to‑80% relief, flare frequency and biomarker area‑under‑the‑curve over time instead of static snapshots.
FDA‑Style Reporting
Export complete trial protocols, power analyses and Monte Carlo confidence intervals as polished PDF deliverables.
Instant Power Forecasting
See how cohort timing, inclusion criteria and adjunct therapies shift your statistical power with a single click.
Benefits
-
Save $500K–$2M in CRO fees by running your own Phase 2 proof‑of‑concept sims.
-
Hit endpoints faster with stratified cohorts and dynamic flare forecasting.
-
Get investor ready: share polished PPT/data exports in minutes.
-
No hidden fees · No per‑seat surcharges · Transparent, all‑inclusive pricing
Custom Plan
Unlimited Active Projects
Spin up as many trial simulations as you need, no caps, no extra fees.
White‑Label & On‑Prem Deployment
Host the platform on your own infrastructure or brand every interface as your own.
Co‑Authorship & Tailored Deliverables
Work side‑by‑side with CYNEARA to produce a co‑branded white paper, fully customized protocols and in‑depth power analyses for each project.
Dedicated 1:1 Advisory
Enjoy unlimited email support and optional weekly strategy session to fine‑tune models, troubleshoot real‑time data and strategize next steps.
Flexible Licensing & Pricing
We’ll craft a plan that fits your exact scope, from seat counts to service levels, so you only pay for what you use.
Perfect for enterprises, CROs or research consortia that demand full control, privacy and a partner who can scale to your ambitions.
What Sets CYNAERA Apart
Transparent, All‑Inclusive Pricing
No hidden seat fees or surprise consulting mark‑ups—everything is on the page, up front.
Live, Ongoing Support
Weekly office hours (Professional) or dedicated 1:1 advisory (Enterprise) keeps you moving. No more ticket‑only black holes.
Flexible Project‑Based Licensing
Spin up a new trial “project” when you need it, archive when you’re done—no shared accounts, no wasted seats.
Modular, Multi‑Indication Framework
Mix and match antivirals, mitochondrial support, microclot clearance, mast‑cell stabilization and cytokine modules in minutes, for any disease area.
Instant Power Forecasting
See on the fly how cohort timing, inclusion criteria and adjunct therapies shift your statistical power, no manual tables needed.
Enterprise‑Exclusive: Co‑Branded White Papers
For Enterprise clients we generate a custom white paper per project, complete with protocol details, Monte Carlo power analyses and key insights, ready to share with stakeholders or publish under your brand.
Bioadaptive Systems Therapeutics™ (BST) and all affiliated modules, including but not limited to the Long COVID Diagnostic Fingerprint™, ICDX™ The IACC Progression Continuum™, PCT™ (Primary Chronic Trigger), PULSE™, and CLARITY™ frameworks — are original works authored and developed by Cynthia Adinig.
These systems are protected under U.S. Provisional Patent Application No. 63/909,951 (Patent Pending).
CYNAERA™ operates as the exclusive commercialization and licensing entity under direct authorization from the inventor, providing sublicenses to research institutions, governments, and private organizations.
All rights reserved. Unauthorized reproduction or derivative use of these systems or their derivative modules without written permission from the inventor is strictly prohibited.